TrialJCO precision oncology2024

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Ilenia Migliaccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.